[go: up one dir, main page]

AR045794A1 - Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico - Google Patents

Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico

Info

Publication number
AR045794A1
AR045794A1 ARP040103395A ARP040103395A AR045794A1 AR 045794 A1 AR045794 A1 AR 045794A1 AR P040103395 A ARP040103395 A AR P040103395A AR P040103395 A ARP040103395 A AR P040103395A AR 045794 A1 AR045794 A1 AR 045794A1
Authority
AR
Argentina
Prior art keywords
compound
formula
amino
reacting
hydroxypropylphosphinic
Prior art date
Application number
ARP040103395A
Other languages
English (en)
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of AR045794A1 publication Critical patent/AR045794A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/306Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere a un procedimiento para preparar derivados de ácido 3-amino-2-hidroxipropilfosfónico, que son valiosos ingredientes activos farmacéuticos y pueden ser empleados, por ejemplo, como antidepresivos. Reivindicación 1: Un procedimiento para preparar un compuesto de fórmula (1) con inclusión de sus enantiómeros o diastereómeros, que comprende: (a) hacer reaccionar un compuesto de fórmula (2) con hexametildisilazano para formar un compuesto de fórmula (3). (b) hacer reaccionar el compuesto de fórmula (3) con epihalohidrina y posterior hidrólisis del aducto resultante para formar un compuesto de fórmula (5); (c) hacer reaccionar el compuesto de fórmula (5) con amoníaco y posterior hidrólisis del resto de fosfinato de etilo para formar el compuesto de fórmula (1), y opcionalmente (d) convertir el compuesto de fórmula (1) en una sal farmacéuticamente aceptable, en la cual R es bencilo o ciclohexilmetilo, y X es halógeno.
ARP040103395A 2003-09-23 2004-09-21 Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico AR045794A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50522003P 2003-09-23 2003-09-23

Publications (1)

Publication Number Publication Date
AR045794A1 true AR045794A1 (es) 2005-11-16

Family

ID=34392994

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103395A AR045794A1 (es) 2003-09-23 2004-09-21 Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico

Country Status (6)

Country Link
US (1) US7186705B2 (es)
EP (1) EP1673377B1 (es)
JP (1) JP4558732B2 (es)
AR (1) AR045794A1 (es)
TW (1) TW200526676A (es)
WO (1) WO2005030781A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
US5300679A (en) 1987-12-04 1994-04-05 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
US5567840A (en) 1989-05-13 1996-10-22 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
IL98502A (en) * 1990-06-22 1998-04-05 Ciba Geigy Ag Aminoalkane phosphinic acid derivatives, process for their preparation and pharmaceutical compositions containing them
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids

Also Published As

Publication number Publication date
EP1673377A1 (en) 2006-06-28
EP1673377B1 (en) 2013-12-25
JP2007506747A (ja) 2007-03-22
TW200526676A (en) 2005-08-16
JP4558732B2 (ja) 2010-10-06
US20050070507A1 (en) 2005-03-31
WO2005030781A1 (en) 2005-04-07
US7186705B2 (en) 2007-03-06

Similar Documents

Publication Publication Date Title
CA2637765A1 (en) Benzamide and heteroarene derivatives
AR031828A2 (es) Procedimientos para la preparacion de compuestos espiro-azabiciclicos utiles en terapia
BR0210071A (pt) Composto, processo para preparar o mesmo, composição farmacêutica, uso de um composto, método para produzir um efeito inibitório de ciclo celular (anti-proliferação celular) em um animal de sangue quente
SG148177A1 (en) Novel cis-imidazolines
UY26332A1 (es) Nuevos derivados del ácido aminodicarboxílico con propiedades farmacéuticas.
BR0212458A (pt) Composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, composição farmacêutica, e, processo para a preparação de um composto ou sais farmaceuticamente aceitável, ou ésteres hidrolizáveis in vivo deste
EA200970296A1 (ru) Содержащие диариловый эфир соединения мочевины
SE0100567D0 (sv) Compounds
PT1140745E (pt) Derivados de colquinol como agentes de danificacao vascular
IL192253A0 (en) Substituted cyclohexylmethyl derivatives
RU2009135621A (ru) Хинолиновые производные для лечения воспалительных заболеваний
WO2006034833A1 (en) Cyclic diarly ureas suitable as tyrosine kinase inhibitors
BRPI0409809A (pt) formulação farmacêutica do sal de sódio de telmisartano
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
GEP20084376B (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
SI1594885T1 (sl) Zdravilo za inhibiranje rasti tumorjev
GEAP202516737A (en) Compounds for treating cancer
MX2022006990A (es) Forma cristalina de un derivado del acido 7h-benzo[7]anuleno-2-car boxilico.
EP4635494A3 (en) AMIDO HETERO-ROMATIC COMPOUNDS
GB0205688D0 (en) Chemical compounds
AR027578A1 (es) Derivados de indano
AR004192A1 (es) Un compuesto de pirimidina, sus sales, procedimientos para su preparacion, una formulacion farmaceutica y un compuesto intermediario
CO5590934A2 (es) Procedimiento de preparacion de derivados de equinocandina
AR011521A1 (es) Un derivado de la prolil-3-(2-naftil) alanil-n-bencil-n-metilamida, un procedimiento para su preparacion y una composicion farmaceutica que lo comprende
AR045794A1 (es) Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico

Legal Events

Date Code Title Description
FA Abandonment or withdrawal